肝脏功能障碍的假定生物标志物在危急性败血症患者中
Logan R Van Nynatten1, Maitray A Patel2, Mark Daley2
1Medicine, Western University, London, ON, Canada.
Clinical and experimental medicine
|January 3, 2025
概括
像ARG1,GSTα,5-NT和SDH这样的新生物标志物显示出检测败血症相关肝损伤的前景. 这些标记物,以及传统的测试,可以改善早期识别和治疗毒症患者的肝功能障碍.
科学领域:
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
- 生物标志物发现发现
背景情况:
- 败血症是全球主要的死亡原因,肝损伤显著增加死亡风险.
- 早期和准确的检测败血症引起的肝功能障碍对于患者的结果至关重要.
- 传统的肝功能障碍生物标志物在败血症的背景下可能存在局限性.
研究的目的:
- 在败血症患者中研究肝损伤的新生物标志物 (ARG1,MDH1,GSTα,5-NT,SDH).
- 将这些新生物标志物的疗效与传统肝功能标志物的疗效进行比较.
- 通过使用统计和机器学习方法来评估这些生物标志物的诊断性能.
主要方法:
- 一项多中心病例控制研究,涉及37名肝功能障碍的败血症患者 (S-HD),37名肝功能障碍的败血症患者 (S-CON) 和18名健康对照人群 (HC).
- 使用多重免疫测试测量五种拟议的生物标志物 (ARG1,MDH1,GSTα,5-NT,SDH) 和传统标志物 (白蛋白,胆红素,ALT,AST,GGT,INR).
- 应用传统的统计分析和机器学习 (随机森林分类) 来比较生物标志物水平和诊断准确性.
主要成果:
- 与S-CON.相比,患有肝功能障碍 (S-HD) 的败血症患者表现出更高的疾病严重性得分 (MODS,SOFA) 和改变的传统肝功能标志物.
- 新型生物标志物ARG1,GSTα,5-NT和SDH在ICU第一天的S-HD患者中显著升高.
- 采用这些生物标志物的随机森林模型在区分肝脏损伤的败血症患者时取得了高的诊断性能 (AUC 0.94).
结论:
- 新型生物标志物ARG1,MDH1,GSTα,5-NT和SDH显示出可能成为与败血症相关的肝功能障碍的早期指标.
- 在机器学习模型中,GSTα和5-NT在识别败血症中的肝损伤方面具有显著价值,独立于传统标记.
- 需要进一步的临床验证,以将这些有前途的生物标志物纳入常规败血症管理协议.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
63
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
63
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37